Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.

[1]  S. Montoto,et al.  Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report , 2017, Bone Marrow Transplantation.

[2]  L. Boltežar,et al.  Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas – a single centre experience , 2016, Radiology and oncology.

[3]  M. Labopin,et al.  Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission , 2016, Bone Marrow Transplantation.

[4]  H. Geinitz,et al.  Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience , 2016, Radiation Oncology.

[5]  M. Labopin,et al.  Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis. , 2015, The Lancet. Haematology.

[6]  J. Esteve,et al.  Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation , 2014, Cancer.

[7]  S. Marnitz,et al.  Long-term results of total body irradiation in adults with acute lymphoblastic leukemia , 2014, Strahlentherapie und Onkologie.

[8]  M. Labopin,et al.  Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Szer,et al.  Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX , 2010, Bone Marrow Transplantation.

[10]  J. Dipersio,et al.  Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose? , 2008, Current opinion in hematology.

[11]  M. Bremer,et al.  Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models , 2007, International journal of radiation biology.

[12]  T. Schultheiss,et al.  Dose response and factors related to interstitial pneumonitis after bone marrow transplant. , 2005, International journal of radiation oncology, biology, physics.

[13]  C. Marchal,et al.  Irradiation corporelle totale en France au cours des 20 dernières années , 2003 .

[14]  J. Bourhis,et al.  Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Singhal,et al.  Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years , 2000, Bone Marrow Transplantation.

[16]  J P Klein,et al.  Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. , 1999, Statistics in medicine.

[17]  P. Franzone,et al.  Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. , 1999, International journal of radiation oncology, biology, physics.

[18]  M. Stovall,et al.  Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Ozsahin,et al.  Is veno-occlusive disease incidence influenced by the total-body irradiation technique? , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[20]  P. Rubin,et al.  Morphological correlates of fractionated radiation of the mouse lung: early and late effects. , 1994, International journal of radiation oncology, biology, physics.

[21]  E. Touboul,et al.  Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. , 1994, International journal of radiation oncology, biology, physics.

[22]  E. Touboul,et al.  Total‐body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients , 1992, Cancer.

[23]  H. Deeg,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. , 1986, Bone marrow transplantation.

[24]  C. Song,et al.  Effect of fractionation and rate of radiation dose on human leukemic cells, HL-60. , 1985, Radiation research.

[25]  R. Storb,et al.  Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. , 1982, International journal of radiation oncology, biology, physics.

[26]  R. Galalae,et al.  Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts. , 2008, International journal of radiation oncology, biology, physics.

[27]  P. Hougaard,et al.  Frailty models for survival data , 1995, Lifetime data analysis.